The expression of c-erbB-2 and p53 proteins showed a large variation between the non-neoplastic ducts and ductal carcinoma in situ components, but most of the cases showed very similar protein expression and good nuclear grade agreement between ductal carcinoma in situ and invasive ductal carcinoma components. The gene discussed is TP53; the disease is invasive ductal breast carcinoma.